Vaxcyte has commenced the Phase II trial of its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31, in healthy infants.

Clinical Trials in Oncology conference a panel urged trial designers to be considerate of what they are asking from patients.

Clinical Trials in Oncology conference, healthcare companies were urged to keep rigorous records during clinical trials.

Vivavision’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a post-op inflammation treatment after cataract surgery.

Arrowhead Pharmaceuticals has sent an application to the New Zealand regulator seeking clearance to commence a Phase I/IIa trial of ARO-ALK7.

GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives ...

Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...

Medicus Pharma has partnered with Swanielle to expand its Phase II trial for treating basal cell carcinoma into the Asia-Pacific region.

Minghui has reported positive topline outcomes from the Phase III trial of MH004 for treating mild to moderate atopic ...

Pneumonia epidemic peaks historically occur every four to seven years, with the last epidemic of pneumonia in the UK occurring in 2019-20.

Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

Sudo Biosciences has begun a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory diseases.